Uptake, Coverage, and Completion of Quadrivalent Human Papillomavirus Vaccine in the Vaccine Safety Datalink, July 2006–June 2011
Mark A. Schmidt(Kaiser Permanente Center for Health Research), Allison L. Naleway(Centers for Disease Control and Prevention), Stephanie A. Irving(Kaiser Permanente Center for Health Research), Rachel Gold(Kaiser Permanente Center for Health Research), Julianne Gee, Matthew F. Daley(Kaiser Permanente), Samantha K. Kurosky(Triangle)
Cited by 21
Related Papers
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|720
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602
Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States.
|PubMed|2014|537